SLC5A2 and type 2 diabetes mellitus: Our GWAS of reported glycosuria during the third trimester of pregnancy has identified associations of genetic variants on chromosome 16 near multiple genes, including SLC5A2, which has been implicated in familial renal glycosuria and the gene product of which is the target of some type 2 diabetes drugs (gliflozins, e.g. Dapagliflozin).